Inventor
John J. Gaudino
Inventor
Boulder, CO, US
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
Y02ATechnologies for adaptation to climate change6%
C07HSugars2%
H05KPrinted circuits2%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
11,104,676Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases202111,028,0934,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors202110,730,8804,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors202010,647,715KRas G12C inhibitors202010,633,381KRas G12C inhibitors202010,519,126Serine/threonine kinase inhibitors201910,189,8454,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors201910,125,134KRas G12C inhibitors20189,708,290'Serine/threonine kinase inhibitors'20179,670,208'Serine/threonine kinase inhibitors'20179,388,171'Serine/threonine kinase inhibitors'20169,259,470'Serine/threonine kinase inhibitors'20169,187,462'Substituted quinazolines as serine/threonine kinase inhibitors'20159,133,187'Serine/threonine kinase inhibitors'20158,697,715'Serine/threonine kinase inhibitors'20148,003,662'Heterobicyclic thiophene compounds and methods of use'20117,723,330'Heterobicyclic pyrazole compounds and methods of use'20107,608,618'Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1'20097,560,462'Compounds useful for inhibiting CHK1'20097,553,842'Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases'20097,176,229'Cyclic AMP-specific phosphodiesterase inhibitors'20077,067,506'Compounds useful for inhibiting Chk1'20066,998,416'Cyclic AMP-specific phosphodiesterase inhibitors'20066,716,871'Cyclic AMP-specific phosphodie sterase inhibitors'20046,586,467'Preparation of phosphatase inhibitors'20036,458,787'Cyclic AMP-specific phosphodiesterase inhibitors'20026,444,671'Cyclic AMP-specific phosphodiesterase inhibitors'20026,423,710'Cyclic AMP-specific phosphodiesterase inhibitors'20026,362,213'Cyclic AMP-specific phosphodiesterase inhibitors'20026,258,833'Cyclic AMP-specific phosphodiesterase inhibitors'20015,811,404'Sialyl Le.sup.x analogues as inhibitors of cellular adhesion'19985,604,207'Sialyl Le.sup.x analogues as inhibitors of cellular adhesion'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–1998Based in Westlake Village, CA, US· patent location history
2001–2009Patents assigned to ICOS CORP (11)· patent assignee history
2001–2021Based in Boulder, CO, US· patent location history
2002–2011Based in Longmont, CO, US· patent location history
2003–2021Patents assigned to ARRAY BIOPHARMA INC (19)· patent assignee history
2010–2019Patents assigned to GENENTECH INC (9)· patent assignee history
2018–2020Patents assigned to MIRATI THERAPEUTICS INC (3)· patent assignee history
2019–2021Patents assigned to CELGENE CORP (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 19 | 2003–2021 |
| ICOS CORP | 11 | 2001–2009 |
| GENENTECH INC | 9 | 2010–2019 |
| CELGENE CORP | 3 | 2019–2021 |
| MIRATI THERAPEUTICS INC | 3 | 2018–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boulder, CO, US | 19 | 2001–2021 |
| Longmont, CO, US | 11 | 2002–2011 |
| Westlake Village, California, US | 2 | 1997–1998 |